Story perspectives

MIT Uncovers Promising Tuberculosis Vaccine Antigens and Treatments

11/6/2025

48 8

Summary

Story summary

Massachusetts Institute of Technology (MIT) researchers identified vaccine antigens for tuberculosis by analyzing immunogenic peptides from more than 4,000 bacterial proteins, aiming to improve protection beyond BCG.
The study, published in Science Translational Medicine, seeks to enhance immune responses by targeting proteins displayed on infected human cells.
A separate study highlights CMX410, a compound targeting a key enzyme in Mycobacterium tuberculosis and showing promise against drug-resistant strains.

1 of 1

Story summary

Massachusetts Institute of Technology (MIT) researchers identified vaccine antigens for tuberculosis by analyzing immunogenic peptides from more than 4,000 bacterial proteins, aiming to improve protection beyond BCG.
The study, published in Science Translational Medicine, seeks to enhance immune responses by targeting proteins displayed on infected human cells.
A separate study highlights CMX410, a compound targeting a key enzyme in Mycobacterium tuberculosis and showing promise against drug-resistant strains.